Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Angelo Davide Contrino"'
CARDIOVASCULAR RISK IN ESSENTIAL THROMBOCYTHEMIA AND POLYCYTHEMIA VERA: THROMBOTIC RISK AND SURVIVAL
Autor:
Vincenzo Accurso, Marco Santoro, Salvatrice Mancuso, Angelo Davide Contrino, Paolo Casimio, Mariano Sardo, Simona Raso, Florinda Di Piazza, Alessandro Perez, Marco Bono, Antonio Russo, Sergio Siragusa
Publikováno v:
Mediterranean Journal of Hematology and Infectious Diseases, Vol 12, Iss 1 (2020)
Abstract Thromboembolic and bleeding events pose a severe risk for patients with Polycythemia Vera (PV) and Essential Thrombocythemia (ET). Many factors can contribute to determine the thrombotic event, including the interaction between platelets,
Externí odkaz:
https://doaj.org/article/ee0f15aa667547ed89c6929f8718e284
Autor:
Salvatrice Mancuso, Vincenzo Accurso, Marco Santoro, Simona Raso, Angelo Davide Contrino, Alessandro Perez, Florinda Di Piazza, Ada Maria Florena, Antonio Russo, Sergio Siragusa
Publikováno v:
Advances in Hematology, Vol 2020 (2020)
Essential thrombocythemia is a rare hematological malignancy with good overall survival, but moderate to high risk of developing arterial or venous thrombosis lifelong. Different thrombotic risk scores for patients with essential thrombocythemia have
Externí odkaz:
https://doaj.org/article/a8040fdf1f9b4b18b89d514b561cde4d
Autor:
Vincenzo Accurso, Marco Santoro, Simona Raso, Angelo Davide Contrino, Paolo Casimiro, Florinda Di Piazza, Alessandro Perez, Antonio Russo, Sergio Siragusa
Publikováno v:
Hematology Reports, Vol 11, Iss 4 (2019)
Splenomegaly is one of the major clinical manifestations of primary myelofibrosis and is common also in other chronic Philadelphia-negative myeloproliferative neoplasms, causing symptoms and signs and affecting quality of life of patients diagnosed w
Externí odkaz:
https://doaj.org/article/4d6ee256346148dabe43cd1d2e146c9c
Autor:
Di Piazza F, Alessandro Perez, Mariano Sardo, Paolo Casimiro, Vincenzo Accurso, Angelo Davide Contrino, Antonio Russo, Marco Santoro, Sergio Siragusa, Melania Carlisi, Simona Raso
Publikováno v:
Journal of Hematology and Clinical Research. 3:053-059
Autor:
Maria Francesca Mansueto, Davide Sirocchi, Mariasanta Napolitano, Simona Raso, Angelo Davide Contrino, Sergio Siragusa
Publikováno v:
Patient preference and adherence
Mariasanta Napolitano, 1 Maria Francesca Mansueto, 1 Davide Sirocchi, 1 Angelo Davide Contrino, 1 Simona Raso, 2 Sergio Siragusa 1 1Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties (PROMISE), Haematolog
CARDIOVASCULAR RISK IN ESSENTIAL THROMBOCYTHEMIA AND POLYCYTHEMIA VERA: THROMBOTIC RISK AND SURVIVAL
Autor:
Florinda Di Piazza, Antonio Russo, Angelo Davide Contrino, Simona Raso, Mariano Sardo, Marco Bono, Paolo Casimiro, Salvatrice Mancuso, Sergio Siragusa, Alessandro Perez, Marco Santoro, Vincenzo Accurso
Publikováno v:
Mediterranean Journal of Hematology and Infectious Diseases, Vol 12, Iss 1 (2020)
Mediterranean Journal of Hematology and Infectious Diseases
Mediterranean Journal of Hematology and Infectious Diseases
Thromboembolic and bleeding events pose a severe risk for patients with Polycythemia Vera (PV) and Essential Thrombocythemia (ET). Many factors can contribute to promoting the thrombotic event due to the interaction between platelets, leukocytes, and
Autor:
Ada Maria Florena, Florinda Di Piazza, Simona Raso, Alessandro Perez, Antonio Russo, Angelo Davide Contrino, Salvatrice Mancuso, Sergio Siragusa, Marco Santoro, Vincenzo Accurso
Publikováno v:
Advances in Hematology
Advances in Hematology, Vol 2020 (2020)
Advances in Hematology, Vol 2020 (2020)
Essential thrombocythemia is a rare hematological malignancy with good overall survival, but moderate to high risk of developing arterial or venous thrombosis lifelong. Different thrombotic risk scores for patients with essential thrombocythemia have
Autor:
Alessandro Perez, Simona Raso, Paolo Casimiro, Angelo Davide Contrino, Antonio Russo, Vincenzo Accurso, Florinda Di Piazza, Marco Santoro, Sergio Siragusa
Publikováno v:
Hematology Reports; Volume 11; Issue 4; Pages: 8281
Hematology Reports
Hematology Reports, Vol 11, Iss 4 (2019)
Hematology Reports
Hematology Reports, Vol 11, Iss 4 (2019)
Splenomegaly is one of the major clinical manifestations of primary myelofibrosis and is common also in other chronic Philadelphia-negative myeloproliferative neoplasms, causing symptoms and signs and affecting quality of life of patients diagnosed w
Autor:
Giuseppina Novo, Marco Santoro, Vincenzo Accurso, Antonio Russo, Alessandro Perez, Angelo Davide Contrino, Sergio Siragusa, Salvatrice Mancuso, Florinda Di Piazza, Mariano Sardo
Cardiovascular (CV) adverse events are considered common complications of ponatinib treatment. Recently, it has been demonstrated that ponatinib dose reductions in definite settings can obtain optimal responses and lower ponatinib-related CV events.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a13e81d6ba591d01434b79d2db455067
http://hdl.handle.net/10447/388111
http://hdl.handle.net/10447/388111
Autor:
Marco Santoro, F. Di Piazza, Mariano Sardo, A. Russo, Ada Maria Florena, Vincenzo Accurso, Angelo Davide Contrino, Sergio Siragusa, Alessandro Perez
Publikováno v:
HemaSphere. 3:1000